<div id="readability-page-1"><p>Abivax, Danaher,  and Cogent Biosciences are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop and commercialize biological technologies, drugs, diagnostics, and related health-care innovations. They are often characterized by heavy R&amp;D spending, reliance on clinical trial outcomes and regulatory approvals, and therefore can be higher-risk but higher-reward than many other sectors. Many biotech firms are small-cap or pre-revenue and dependent on partnerships, patents and external financing for growth. These companies had the highest dollar trading volume of any Biotech stocks within the last several days.</p><h2>Abivax (ABVX)</h2><p>ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults.</p><p>Read Our Latest Research Report on ABVX</p><h2>Danaher (DHR)</h2><p>Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.</p><p>Read Our Latest Research Report on DHR</p><h2>Cogent Biosciences (COGT)</h2><p>Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors.</p><p>Read Our Latest Research Report on COGT</p><h2>Recommended Stories</h2><ul><li>MarketBeat's Top Five Stocks to Own in December 2025</li><li>The Kroger Catalyst: $2 Billion Reasons to Buy</li><li>Why Wall Street Gave Up on Pfizer—and Why That May Be a Mistake</li><li>Gold, Silver, and Copper Are Surging—Here Are 3 Smart Ways to Play It</li><li>What to Expect From Amazon in the 4 Weeks Before Earnings</li><li>How the Mag 7’s 2025 Laggards Could Turn Into 2026 Winners</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Abivax Right Now?</h2><p>Before you consider Abivax, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Abivax wasn't on the list.</p><p>While Abivax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

COGT

ABVX

<p>Abivax, Danaher, and Cogent Biosciences are highlighted as key biotech stocks to watch today, according to MarketBeat. Abivax focuses on therapies for chronic inflammatory diseases, Danaher provides bioprocess technologies, and Cogent develops precision therapies for genetically defined diseases. These companies are characterized by high R&D spending and reliance on clinical trials, making them higher-risk but potentially higher-reward investments. They had the highest trading volumes in the biotech sector recently.</p>

Best Biotech Stocks To Follow Today - December 31st